|
1
|
Howlader N, Noone AM, Krapcho M, et al:
SEER Cancer Statistics Review, 1975–2014. National Cancer
Institute; Bethesda, MD: https://seer.cancer.gov/csr/1975_2014/based on
November 2016 SEER data submission, posted to the SEER web site.
April. 2017
|
|
2
|
Davies L and Welch HG: Current thyroid
cancer trends in the United States. JAMA Otolaryngol Head Neck
Surg. 140:317–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Durante C, Haddy N, Baudin E, Leboulleux
S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De
Vathaire F and Schlumberger M: Long-term outcome of 444 patients
with distant metastases from papillary and follicular thyroid
carcinoma: Benefits and limits of radioiodine therapy. J Clin
Endocrinol Metab. 91:2892–2899. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Thyroid Association (ATA)
Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid
Cancer, . Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL,
Mandel SJ, Mazzaferri EL, McIver B, Pacini F, et al: Revised
American Thyroid Association management guidelines for patients
with thyroid nodules and differentiated thyroid cancer. Thyroid.
19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ito Y and Miyauchi A: Nonoperative
management of low-risk differentiated thyroid carcinoma. Curr Opin
Oncol. 27:15–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wada N, Duh QY, Sugino K, Iwasaki H,
Kameyama K, Mimura T, Ito K, Takami H and Takanashi Y: Lymph node
metastasis from 259 papillary thyroid microcarcinomas: Frequency,
pattern of occurrence and recurrence, and optimal strategy for neck
dissection. Ann Surg. 237:399–407. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T,
Xiao B and Guo J: Decreased expression of long noncoding RNA
AC096655.1-002 in gastric cancer and its clinical significance.
Tumour Biol. 34:2697–2701. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun M, Jin FY, Xia R, Kong R, Li JH, Xu
TP, Liu YW, Zhang EB, Liu XH and De W: Decreased expression of long
noncoding RNA GAS5 indicates a poor prognosis and promotes cell
proliferation in gastric cancer. BMC Cancer. 14:3192014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ge X, Chen Y, Liao X, Liu D, Li F, Ruan H
and Jia W: Overexpression of long noncoding RNA PCAT-1 is a novel
biomarker of poor prognosis in patients with colorectal cancer. Med
Oncol. 30:5882013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu JH, Chen G, Dang YW, Li CJ and Luo DZ:
Expression and prognostic significance of lncRNA MALAT1 in
pancreatic cancer tissues. Asian Pac J Cancer Prev. 15:2971–2977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braconi C, Kogure T, Valeri N, Huang N,
Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM and Patel T:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv N, Shan Z, Gao Y, Guan H, Fan C, Wang H
and Teng W: Twist1 regulates the epithelial-mesenchymal transition
via the NF-kB pathway in papillary thyroid carcinoma. Endocrine.
51:469–477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leboulleux S, Tuttle RM, Pacini F and
Schlumberger M: Papillary thyroid microcarcinoma: Time to shift
from surgery to active surveillance? Lancet Diabetes Endocrinol.
4:933–942. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan YH, Ding J, Nguyen S, Liu XJ, Xu G,
Zhou HY, Duan NN, Yang SM, Zern MA and Wu J: Aberrant hedgehog
signaling is responsible for the highly invasive behavior of a
subpopulation of hepatoma cells. Oncogene. 35:116–124. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang C: Abstract 426: Suppression of cell
invasion and migration by inhibitors to ROS level in human lung
cancer cells. Cancer Res. 70:426. 2010. View Article : Google Scholar
|
|
19
|
Lu KV, Jong KA, Rajasekaran AK, Cloughesy
TF and Mischel PS: Upregulation of tissue inhibitor of
metalloproteinases (TIMP)-2 promotes matrix metalloproteinase
(MMP)-2 activation and cell invasion in a human glioblastoma cell
line. Lab Invest. 84:8–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
William S: Guidance document on the
recognition, assessment, and use of clinical signs as humane
endpoints for experimental animals used in safety evaluation. OECD
Environmental Health and Safety Publications, Series on Testing and
Assessment 19; 2000
|
|
21
|
Patterson TA, Lobenhofer EK,
Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, Fang H, Kawasaki ES,
Hager J, Tikhonova IR, et al: Performance comparison of one-color
and two-color platforms within the MicroArray quality control
(MAQC) project. Nat Biotechnol. 24:1140–1150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xing M, Haugen BR and Schlumberger M:
Progress in molecular-based management of differentiated thyroid
cancer. Lancet. 381:1058–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu R, Bishop J, Zhu G, Zhang T, Ladenson
PW and Xing M: Mortality risk stratification by combining BRAF
V600E and TERT promoter mutations in papillary thyroid cancer:
Genetic duet of BRAF and TERT promoter mutations in thyroid cancer
mortality. JAMA Oncol. Sep 1–2016.(Epub ahead of print).
|
|
26
|
Carr FE, Tai PW, Barnum MS, Gillis NE,
Evans KG, Taber TH, White JH, Tomczak JA, Jaworski DM, Zaidi SK, et
al: Thyroid hormone receptor-β (TRβ) mediates runt-related
transcription factor 2 (Run×2) expression in thyroid cancer cells:
A novel signaling pathway in thyroid cancer. Endocrinology.
157:3278–3292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joung JY, Kim TH, Jeong DJ, Park SM, Cho
YY, Jang HW, Jung YY, Oh YL, Yim HS, Kim YL, et al: Diffuse
sclerosing variant of papillary thyroid carcinoma: Major genetic
alterations and prognostic implications. Histopathology. 69:45–53.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sidaway P: Thyroid cancer: BRAF and/or
TERT mutations increase mortality. Nat Rev Clin Oncol. 13:6522016.
View Article : Google Scholar
|
|
29
|
Gupta Chandra S and Tripathi Nandan Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eades G, Zhang YS, Li QL, Xia JX, Yao Y
and Zhou Q: Long non-coding RNAs in stem cells and cancer. World J
Clin Oncol. 5:134–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moran VA, Perera RJ and Khalil AM:
Emerging functional and mechanistic paradigms of mammalian long
non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoon H, He H, Nagy R, Davuluri R, Suster
S, Schoenberg D, Pellegata N and Ade Chapelle L: Identification of
a novel noncoding RNA gene, NAMA, that is downregulated in
papillary thyroid carcinoma with BRAF mutation and associated with
growth arrest. Int J Cancer. 121:767–775. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Hu
J and Sun Y: BRAF-activated long non-coding RNA contributes to cell
proliferation and activates autophagy in papillary thyroid
carcinoma. Oncol Lett. 8:1947–1952. 2014. View Article : Google Scholar : PubMed/NCBI
|
